Basiem

---

Usual adult dose is 1-2 tablets twice daily or as prescribed by a licensed medical practitioner.

---

Persons 12 years and older: Apply Adiposix BIOfrequency Chip below the naval of intact skin. Adiposix BIOfrequency Chip can be used up to24 hours of continuous use.

Instructions for Use

Clean and dry affected area. Shaving excess hair may help adhesion of Adiposix BIOfrequency Chip. Open pouch and remove the Adiposix BIOfrequency Chip card that contains 3 biofrequency chips. Remove one Adiposix BIOfrequency Chip from the card and apply sticky side directly to area immediately below the naval. For optimal coverage, apply an additional Adiposix BIOfrequency Chip to the left of the naval, and another one to the right of the navel Replace as needed. Wash hands with soap after applying Adiposix BIOfrequency Chip. Reseal pouch containing unused Adiposix BIOfrequency Chips. Fold used Adiposix BIOfrequency Chip so that the adhesive side sticks to itself and safely discard used Adiposix BIOfrequency Chip where children and pets cannot get to them.

Children under 12 years, consult a physician before use.

---

Megrix OTC BIOfrequency chip is supplied in the following dosage form:  30 medicated BIOfrequency chips containing 2.5% menthol and 0.0018% capsaicin  [(2 per individually wrapped sterile package) x 15]

Apply 2 Megrix OTC BIOfrequency chips to the affected area of intact skin.

Clean and dry affected area. Shaving excess hair may help adhesion of biofrequency chip. Open pouch and remove one Megrix OTC BIOfrequency chip card that contains 2 BIOfrequency chips. Remove two medicated biofrequency chips from the card and apply sticky side directly to area of pain. In the case of migraine pain, apply one BIOfrequency chip to each temple or two on the base of the neck. Apply two BIOfrequency chips to affected area two (2) times daily or every 12 hours. Wash hands with soap after applying Megrix OTC BIOfrequency chip. Reseal pouch containing unused Megrix OTC BIOfrequency chips. Once the sterile packaging is opened, utilize both biofrequency chips. Do not store unused Megrix OTC BIOfrequency chips outside the sterile packaging or an opened package. Fold used Megrix OTC BIOfrequency chips so that the adhesive side sticks to itself and safely discard used Megrix OTC BIOfrequency chips where children and pets cannot get to them.

---

Pallerix OTC BIOfrequency chip is supplied in the following dosage form:  30 medicated biofrequency chips containing 2.5% menthol and 0.0018% capsaicin  [(2 per individually wrapped sterile package) x 15].

Apply 2 Pallerix OTC BIOfrequency chips to the affected area of intact skin. 

Clean and dry affected area. Shaving excess hair may help adhesion of BIOfrequency chip. Open pouch and remove one Pallerix OTC BIOfrequency chip card that contains 2 biofrequency chips. Remove two BIOfrequency chips from the card and apply sticky side directly to area of pain. Apply two medicated biofrequency chips to affected area two (2) times daily or every 12 hours. Wash hands with soap after applying Pallerix OTC BIOfrequency chips. Reseal pouch containing unused Pallerix OTC BIOfrequency chips. Once the sterile packaging is opened, utilize both biofrequency chips. Do not store unused Pallerix OTC BIOfrequency chips outside the sterile packaging or an opened package. Fold used Pallerix OTC BIOfrequency chips so that the adhesive side sticks to itself and safely discard used Pallerix OTC BIOfrequency chips where children and pets cannot get to them.

---

The adult dose of SULFZIX is 1-2 servings twice a day, or 400–800mg sodium polysulthionate and 1-2mg 5-methyltetrahydrofolate twice per day (BID). For people who are sensitive to medications, a starting dose of 1 serving twice daily is recommended for the first week prior to titrating to a higher dose of 800mg twice daily if warranted. One to two (1-2) servings can be administered twice daily with or without food or as directed under medical supervision.

Pour serving size of 0.014 ounces into cup or glass

Add at least 4 oz of water (or other liquid as preferred) Stir until fully mixed Drink all of the contents immediately Alternatively, product can be mixed with foods such as pudding or yogurt A recommended dose is 1 to 2 servings twice daily or as directed by the healthcare provider.

PATIENT INFORMATION:SULFZIX is a prescription medical food to be used only under licensed medical supervision and direction. Your licensed medical practitioner may choose to prescribe SULFZIX along with other medications.

---

Megrix biofrequency chip is supplied in the following dosage form:  30 medicated biofrequency chips containing 5.0% menthol and 0.0375% capsaicin  [(2 per individually wrapped sterile package) x 15]

Apply 2 Megrix biofrequency chips to the affected area of intact skin.

Clean and dry affected area. Shaving excess hair may help adhesion of biofrequency chip. Open pouch and remove one Megrix biofrequency chip card that contains 2 biofrequency chips. Remove two medicated biofrequency chips from the card and apply sticky side directly to area of pain. In the case of migraine pain, apply one biofrequency chip to each temple or two on the base of the neck. Apply two medicated biofrequency chips to affected area two (2) times daily or every 12 hours. Wash hands with soap after applying Megrix biofrequency chip. Reseal pouch containing unused Megrix biofrequency chips. Once the sterile packaging is opened, utilize both biofrequency chips. Do not store unused Megrix biofrequency chips outside the sterile packaging or an opened package. Fold used Megrix biofrequency chips so that the adhesive side sticks to itself and safely discard used Megrix biofrequency chips where children and pets cannot get to them.

---

Pallerix biofrequency chip is supplied in the following dosage form:  30 medicated biofrequency chips containing 5.0% menthol and 0.0375% capsaicin  [(2 per individually wrapped sterile package) x 15].

Apply 2 Pallerix biofrequency chips to the affected area of intact skin. 

Clean and dry affected area. Shaving excess hair may help adhesion of biofrequency chip. Open pouch and remove one Pallerix biofrequency chip card that contains 2 biofrequency chips. Remove two medicated biofrequency chips from the card and apply sticky side directly to area of pain. Apply two medicated biofrequency chips to affected area two (2) times daily or every 12 hours. Wash hands with soap after applying Pallerix biofrequency chips. Reseal pouch containing unused Pallerix biofrequency chips. Once the sterile packaging is opened, utilize both biofrequency chips. Do not store unused Pallerix biofrequency chips outside the sterile packaging or an opened package. Fold used Pallerix biofrequency chips so that the adhesive side sticks to itself and safely discard used Pallerix biofrequency chips where children and pets cannot get to them.

---

There is currently no dosage information available for this product. We apologize for any inconvenience.

---

There is currently no dosage information available for this product. We apologize for any inconvenience.

---

There is currently no dosage information available for this product. We apologize for any inconvenience.

---

DOSAGE AND ADMINISTRATION:

Carefully consider the potential benefits and risks of naproxen tablets, USP and other treatment options before deciding to use naproxen tablets, USP. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS).After observing the response to initial therapy with naproxen tablets, USP, the dose and frequency should be adjusted to suit an individual patient’s needs.

Different dose strengths and formulations (i.e., tablets, suspension) of the drug are not necessarily bioequivalent. This difference should be taken into consideration when changing formulation.

Although naproxen tablets, USP, naproxen suspension, naproxen delayed-release tablets, and naproxen sodium tablets all circulate in the plasma as naproxen, they have pharmacokinetic differences that may affect onset of action. Onset of pain relief can begin within 1 hour in patients taking naproxen.

The recommended strategy for initiating therapy is to choose a formulation and a starting dose likely to be effective for the patient and then adjust the dosage based on observation of benefit and/or adverse events. A lower dose should be considered in patients with renal or hepatic impairment or in elderly patients (see WARNINGS and PRECAUTIONS).

Geriatric Patients Studies indicate that although total plasma concentration of naproxen is unchanged, the unbound plasma fraction of naproxen is increased in the elderly. Caution is advised when high doses are required and some adjustment of dosage may be required in elderly patients. As with other drugs used in the elderly, it is prudent to use the lowest effective dose.

Patients With Moderate to Severe Renal Impairment Naproxen-containing products are not recommended for use in patients with moderate to severe and severe renal impairment (creatinine clearance <30 mL/min) (see WARNINGS: Renal Effects).

Rheumatoid Arthritis, Osteoarthritis and Ankylosing Spondylitis: Naproxen Tablets, USP 500 mg twice daily

During long-term administration, the dose of naproxen may be adjusted up or down depending on the clinical response of the patient. A lower daily dose may suffice for long-term administration. The morning and evening doses do not have to be equal in size and the administration of the drug more frequently than twice daily is not necessary.In patients who tolerate lower doses well, the dose may be increased to naproxen 1500 mg/day for limited periods of up to 6 months when a higher level of antiinflammatory/analgesic activity is required. When treating such patients with naproxen 1500 mg/day, the physician should observe sufficient increased clinical benefits to offset the potential increased risk. The morning and evening doses do not have to be equal in size and administration of the drug more frequently than twice daily does not generally make a difference in response (see CLINICAL PHARMACOLOGY).

Acute Gout The recommended starting dose is 750 mg of naproxen tablets, USP followed by 250 mg every 8 hours until the attack has subsided.

DOSAGE AND ADMINISTDRATION

Apply MaC Patch to intact skin to cover the area most sensitive to pain. Each patch should not be applied for more than 8 hours in a given 24-hour period. Patches may be cut into smaller sizes with scissors prior to removal of the release liner. Clothing may be worn over the area of application. Smaller areas of treatment are recommended in a debilitated patient, or a patient with impaired elimination.

If irritation or a burning sensation occurs during application, remove the patch and do not reapply until the irritation subsides. When MaC Patch is used concomitantly with other products containing same or similar agents, the amount absorbed from all formulations must be considered

---

The adult dose of XIZFLUS is 1-2 servings twice a day, or 400–800mg sodium polysulthionate and 0.5-1mg 5-methyltetrahydrofolate twice per day (BID). For people who are sensitive to medications, a starting dose of 1 serving twice daily is recommended for the first week prior to titrating to a higher dose of 800mg twice daily if warranted. One to two (1-2) servings can be administered twice daily with or without food or as directed under medical supervision.

---

DOSAGE AND ADMINISTRATION

For most patients, the recommended dose of cyclobenzaprine hydrochloride tablets, USP is 5 mg three times a day. Based on individual patient response, the dose may be increased to 10 mg three times a day. Use of cyclobenzaprine hydrochloride tablets, USP for periods longer than two or three weeks is not recommended (see INDICATIONS AND USAGE).Less frequent dosing should be considered for hepatically impaired or elderly patients (see PRECAUTIONS, Impaired Hepatic Function, and Use in the Elderly).

DOSAGE AND ADMINISTRATION

Apply MaC Patch to intact skin to cover the area most sensitive to pain. Each patch should not be applied for more than 8 hours in a given 24-hour period. Patches may be cut into smaller sizes with scissors prior to removal of the release liner. Clothing may be worn over the area of application. Smaller areas of treatment are recommended in a debilitated patient, or a patient with impaired elimination.

If irritation or a burning sensation occurs during application, remove the patch and do not reapply until the irritation subsides. When MaC Patch is used concomitantly with other products containing same or similar agents, the amount absorbed from all formulations must be considered